Skip to content

Cardiovascular effects of super short intense acceleration training in men with high blood pressure

Cardiovascular effects of super sprints training shorts in men with arterial hypertension

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2vmgq95
Enrollment
Unknown
Registered
2024-08-01
Start date
2024-04-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

This is a randomized clinical trial with an acute stage with twenty normotensive participants and a chronic stage with forty-two hypertensive men. In the acute stage, participants will be divided into
G11.427.410.698.277.311.250

Sponsors

Universidade Federal de Mato Grosso do Sul - UFMS
Lead Sponsor
Universidade Federal de Mato Grosso do Sul - UFMS
Collaborator

Eligibility

Sex/Gender
Male
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Men. Age between thirty and sixty years. Previous medical diagnosis of primary hypertension or use of at least one antihypertensive medication. Stage one arterial hypertension diagnosed at least one year ago. If taking antihypertensive medication that has not changed for at least two months. Have not participated in regular exercise programs in the last three months prior to the study. Agree to sign the informed consent form. Volunteers without arterial hypertension must only meet the criteria for males. Age between thirty and sixty years. Abstained from regular exercise in the last three months. Agree to sign the informed consent form

Exclusion criteria

Exclusion criteria: Significant comorbidities such as heart failure; chronic obstructive pulmonary disease; changes in cognitive impairment or psychiatric illness; previous stroke; neuromuscular disease; asthma; uncontrolled diabetes; peripheral vascular disease; grade three obesity; renal failure; sleep apnea; malnutrition or other diseases that interfere with protocol performance; secondary hypertension; individuals with contraindications to performing a symptom-limited maximal exercise test

Design outcomes

Primary

MeasureTime frame
The main outcome that is measured at the end of the study to compare two interval training protocols in the acute phase and verify the effects of sSIT training in hypertensive patients is blood pressure. In the acute phase being analyzed during exercise and every 15 min for 60 min and in the chronic phase by monitoring blood pressure during exercise and post exercise using an Ambulatory Blood Pressure Monitor (ABPM) for 24 hours.

Secondary

MeasureTime frame
For secondary outcomes, heart rate recovery (HRF), Double Product values and nitric oxide dosage will be verified in both phases of the study.

Countries

Brazil

Contacts

Public ContactGisele Barbosa

Universidade Federal de Mato Grosso do Sul

gisele_walter@hotmail.com+55 (67) 999076499

Outcome results

None listed

Source: REBEC (via WHO ICTRP)